cyclosporine has been researched along with Corneal Diseases in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (27.45) | 18.2507 |
2000's | 17 (33.33) | 29.6817 |
2010's | 17 (33.33) | 24.3611 |
2020's | 3 (5.88) | 2.80 |
Authors | Studies |
---|---|
Brzheskiy, VV | 1 |
Chodosh, J; Hall, LN; Rashad, R; Saeed, HN; Shanbhag, SS | 1 |
Barão, RC; Guerra, PS; Leal, I; Marques, RE; Quintas, AM; Rodrigues, W | 1 |
Halfwassen, C; Scholz, SL; Steuhl, KP; Thomasen, H; Westekemper, H | 1 |
Gao, H; Li, S; Li, Z; Liu, T; Shi, W; Wei, C; Zhang, T | 1 |
Meneghim, RLFS; Natsuaki, KL; Oliveira, AC; Padovani, CR; Satto, LH; Schellini, SA; Viveiros, MMH | 1 |
Braghiroli, M; Demarinis, G; Fossarello, M; Iovino, C; Napoli, PE | 1 |
Carreño, NI; Galvis, V; Revelo, ML; Tello, A | 1 |
Chen, M; Shi, W; Wu, X; Xie, L | 2 |
Hong, J; Liu, Z; Sun, X; Xu, J | 1 |
Lee, NY; Lyu, B; Oh, SH; Yim, HB | 1 |
Satake, Y; Shimazaki, J; Shimazaki-Den, S; Shimmura, S; Shimmura-Tomita, M; Yamamoto, S | 1 |
Unal, M; Yücel, I | 1 |
Bonferoni, MC; Caramella, C; Ferrari, F; Gokce, EH; Güneri, T; Rossi, S; Sandri, G | 1 |
Pandit, RT | 1 |
Akpek, EK; Shan, SJ; Wu, EI | 1 |
Farid, SF; Zaki, AA | 1 |
Sharma, N; Sinha, R; Vajpayee, RB; Vishnu, S | 1 |
Asfuroğlu, E; Toker, E | 1 |
Nakamura, M; Oda, T; Shii, D | 1 |
George, RE; Sugandhi, P | 1 |
Han, ES; Kim, MK; Lee, JH; Wee, WR | 1 |
Birnbaum, F; Böhringer, D; Eberwein, P; Reinhard, T; Schwartzkopff, J | 1 |
Cheng, J; Qi, X; Xie, L; Zhao, J | 1 |
Chen, M; Gao, H; Liu, M; Shi, W; Wang, T; Wu, X; Xie, L; Zhao, J | 1 |
Aldazábal, P; Durán De La Colina, J; García-Urquía, N; Mendicute, J; Rodríguez-Agirretxe, I | 1 |
Behrens-Baumann, W; Lins, H; Schmitz, K | 1 |
Berschick, P; Böhringer, D; Enczmann, J; Henke, L; Kontopoulos, T; Reinhard, T; Spelsberg, H; Sundmacher, R; Wernet, P | 1 |
Blanco, G; Dios, E; Herreras, JM; Mayo, A | 1 |
Al-Amri, A; Al-Torbak, A; Wagoner, MD | 1 |
Price, FW; Price, MO | 1 |
Afshari, NA; Heitman, J; Onyewu, C | 1 |
Erbilen, E; Tunc, M | 1 |
Böhringer, D; Maier, P; Reinhard, T | 1 |
Tsai, RJ; Tseng, SC | 1 |
Benítez del Castillo, JM; del Aguila, C; Duran, S; García Sánchez, J; Hernandez, J | 1 |
Rakic, JM | 1 |
Kaan, G; Ozden, O | 1 |
Buckley, RJ; Ficker, LA; Tan, DT | 1 |
Matthews, AG | 1 |
Saito, H; Shimazaki, J; Shinozaki, N; Toda, I; Tsubota, K | 1 |
Williams, DL | 1 |
Wu, Y; Xu, KP; Zhang, X; Zhou, J | 1 |
Borderie, VM; Laroche, L; Touzeau, O | 1 |
Möller, M; Reinhard, T; Sundmacher, R | 1 |
Althaus, C; Reinhard, T; Spelsberg, H; Sundmacher, R | 1 |
Meller, D; Tseng, SC | 1 |
Daya, SM; Ilari, L | 1 |
Chalmers, A; Dubord, PJ; Kassen, BO; McCarthy, JM; Rangno, KK | 1 |
Heering, P; Reinhard, T; Sundmacher, R | 1 |
3 review(s) available for cyclosporine and Corneal Diseases
Article | Year |
---|---|
Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection.
Topics: Corneal Diseases; Cyclosporine; Dermatologic Agents; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Retrospective Studies; Vision Disorders | 2022 |
[Ocular graft versus host disease : Corneal complications].
Topics: Adrenal Cortex Hormones; Chronic Disease; Combined Modality Therapy; Corneal Diseases; Corneal Ulcer; Cyclosporine; Diagnosis, Differential; Eye Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Keratoplasty, Penetrating; Limbus Corneae; Ophthalmic Solutions; Tacrolimus | 2017 |
A comparative approach to topical cyclosporine therapy.
Topics: Administration, Topical; Animals; Cats; Corneal Diseases; Corneal Transplantation; Cyclosporine; Dog Diseases; Dogs; Graft Rejection; Immunosuppressive Agents; Keratoconjunctivitis Sicca | 1997 |
6 trial(s) available for cyclosporine and Corneal Diseases
Article | Year |
---|---|
Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence.
Topics: Adult; Combined Modality Therapy; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Postoperative Care; Preoperative Care; Prospective Studies; Pterygium; Recurrence; Surgical Flaps; Young Adult | 2019 |
Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.
Topics: Administration, Topical; Adult; Aged; Corneal Diseases; Corneal Transplantation; Cyclosporine; Dexamethasone; Drug Administration Routes; Endothelium, Corneal; Female; Graft Rejection; Graft vs Host Reaction; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome | 2008 |
Topical cyclosporine.
Topics: Administration, Topical; Corneal Diseases; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Prospective Studies; Recurrence; Time Factors; Treatment Outcome; Visual Acuity | 2009 |
A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
Topics: Adult; Blindness; Cell Count; Corneal Diseases; Cyclosporine; Drug Delivery Systems; Endothelium, Corneal; Equipment Design; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Male; Middle Aged; Prognosis; Retrospective Studies; Young Adult | 2013 |
Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Corneal Diseases; Corneal Transplantation; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Prospective Studies; Treatment Outcome | 2006 |
Homologous penetrating central limbo-keratoplasty (HPCLK) in bilateral limbal stem cell insufficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Transplantation; Child; Child, Preschool; Corneal Diseases; Cyclosporine; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Limbus Corneae; Middle Aged; Retrospective Studies; Stem Cells; Transplantation, Homologous; Treatment Outcome | 1999 |
42 other study(ies) available for cyclosporine and Corneal Diseases
Article | Year |
---|---|
[Modern possibilities of pathogenetically oriented therapy for dry eye syndrome].
Topics: Conjunctiva; Conjunctivitis, Allergic; Corneal Diseases; Cyclosporine; Dry Eye Syndromes; Humans; Immunosuppressive Agents; Keratitis; Ophthalmic Solutions; Tears | 2023 |
The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease.
Topics: Cohort Studies; Corneal Diseases; Cyclosporine; Follow-Up Studies; Humans; Retrospective Studies; Stevens-Johnson Syndrome; Visual Acuity | 2021 |
Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
Topics: Animals; Cornea; Corneal Diseases; Corneal Pachymetry; Corneal Transplantation; Cyclosporine; Drug Delivery Systems; Graft Rejection; Graft Survival; Immunosuppressive Agents; Keratoplasty, Penetrating; Male; Rabbits | 2018 |
A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
Topics: Administration, Topical; Adult; Corneal Diseases; Cyclosporine; Dry Eye Syndromes; Epithelium, Corneal; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Particle Size; Retrospective Studies; Surface Properties | 2019 |
Intracameral cyclosporine drug delivery system in high-risk keratoplasty.
Topics: Blindness; Corneal Diseases; Cyclosporine; Drug Delivery Systems; Endothelium, Corneal; Female; Graft Rejection; Humans; Keratoplasty, Penetrating; Male | 2013 |
Author reply: To PMID 23246118.
Topics: Blindness; Corneal Diseases; Cyclosporine; Drug Delivery Systems; Endothelium, Corneal; Female; Graft Rejection; Humans; Keratoplasty, Penetrating; Male | 2013 |
Cyclosporine a drug-delivery system for high-risk keratoplasty.
Topics: Blindness; Corneal Diseases; Cyclosporine; Drug Delivery Systems; Endothelium, Corneal; Female; Graft Rejection; Humans; Keratoplasty, Penetrating; Male | 2013 |
Author reply: To PMID 23246118.
Topics: Blindness; Corneal Diseases; Cyclosporine; Drug Delivery Systems; Endothelium, Corneal; Female; Graft Rejection; Humans; Keratoplasty, Penetrating; Male | 2013 |
Lower Lid Laxity is Negatively Correlated with Improvement of the Ocular Surface Disease Index in Dry Eye Treatment.
Topics: Corneal Diseases; Cyclosporine; Dry Eye Syndromes; Eyelids; Female; Fluorometholone; Glucocorticoids; Humans; Immunosuppressive Agents; Lubricant Eye Drops; Male; Middle Aged; Oculomotor Muscles; Surveys and Questionnaires; Tears | 2016 |
[Factors Affecting Outcomes of Repeated Penetrating Keratoplasty].
Topics: Aged; Corneal Diseases; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Male; Middle Aged; Prognosis; Reoperation; Retrospective Studies; Treatment Outcome; Visual Acuity | 2015 |
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
Topics: Animals; Calorimetry, Differential Scanning; Cell Survival; Corneal Diseases; Cyclosporine; Drug Compounding; Electrochemistry; Epithelial Cells; Excipients; Fluorescent Dyes; Immunosuppressive Agents; In Vitro Techniques; Microscopy, Confocal; Microscopy, Electron, Transmission; Neutral Red; Particle Size; Rhodamines; Sterilization; Surface-Active Agents; Swine | 2008 |
Dendriform filamentary keratopathy.
Topics: Acute Disease; Arthritis, Rheumatoid; Cornea; Corneal Diseases; Cyclosporine; Diagnosis, Differential; Drug Administration Schedule; Epithelium, Corneal; Humans; Male; Middle Aged; Prednisolone; Severity of Illness Index | 2009 |
Sterile corneal melt after descemet stripping endothelial keratoplasty in patients with previously undiagnosed Sjogren syndrome.
Topics: Aged, 80 and over; Corneal Diseases; Corneal Transplantation; Cyclosporine; Descemet Membrane; Drug Therapy, Combination; Endothelium, Corneal; Fuchs' Endothelial Dystrophy; Humans; Male; Methotrexate; Postoperative Complications; Prednisone; Sjogren's Syndrome | 2009 |
Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Topics: Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Eye Neoplasms; Female; Follow-Up Studies; Humans; Male; Mitomycin; Neoplasm Invasiveness; Ophthalmologic Surgical Procedures; Treatment Outcome | 2009 |
Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Topics: Administration, Topical; Adult; Aged; Conjunctival Diseases; Corneal Diseases; Cyclosporine; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Humans; Hypesthesia; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Surveys and Questionnaires; Tears; Young Adult | 2010 |
Transfer of a T-helper type 2 clone into conjunctiva induces corneal damage in mice.
Topics: Animals; Betamethasone; Cell Culture Techniques; Clone Cells; Conalbumin; Conjunctiva; Conjunctivitis, Allergic; Corneal Diseases; Cyclosporine; Disease Models, Animal; Eosinophil Peroxidase; Eosinophilia; Female; Glucocorticoids; Immunosuppressive Agents; Interleukin-5; Lymphocyte Activation; Mice; Mice, Inbred AKR; Th2 Cells | 2010 |
Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Mitomycin; Ophthalmologic Surgical Procedures | 2011 |
Long-term outcome and prognostic factor analysis for keratolimbal allografts.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Corneal Diseases; Cyclosporine; Epithelium, Corneal; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Limbus Corneae; Male; Middle Aged; Ofloxacin; Postoperative Complications; Prednisolone; Prognosis; Proportional Hazards Models; Retrospective Studies; Stem Cell Transplantation; Stem Cells; Transplantation, Homologous; Treatment Outcome | 2011 |
Allogenic limbo-keratoplasty with conjunctivoplasty, mitomycin C, and amniotic membrane for bilateral limbal stem cell deficiency.
Topics: Adult; Alkylating Agents; Amnion; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Limbus Corneae; Male; Middle Aged; Mitomycin; Mycophenolic Acid; Retrospective Studies; Stem Cells; Transplantation, Homologous; Visual Acuity | 2012 |
Clinical results and influential factors of modified large-diameter lamellar keratoplasty in the treatment of total limbal stem cell deficiency.
Topics: Burns, Chemical; Cornea; Corneal Diseases; Corneal Transplantation; Cyclosporine; Epithelium, Corneal; Eye Burns; Eyelids; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Limbus Corneae; Male; Plastic Surgery Procedures; Postoperative Complications; Risk Factors; Stem Cells; Tears; Treatment Outcome; Visual Acuity | 2013 |
[Study of two immunosuppresive strategies after limbal allograft transplantation].
Topics: Animals; Burns, Chemical; Corneal Diseases; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Epithelium, Corneal; Eye Burns; Glucocorticoids; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Limbus Corneae; Rabbits; Sodium Hydroxide; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2003 |
Bilateral spontaneous corneal perforation associated with complete external ophthalmoplegia in mitochondrial myopathy (kearns-sayre syndrome).
Topics: Adult; Conjunctivitis; Corneal Diseases; Corneal Ulcer; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kearns-Sayre Syndrome; Keratitis; Keratoplasty, Penetrating; Ophthalmoplegia, Chronic Progressive External; Rupture, Spontaneous; Visual Acuity | 2003 |
Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency.
Topics: Adult; Cell Survival; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Histocompatibility Testing; Humans; Immunogenetics; Immunosuppressive Agents; Keratoplasty, Penetrating; Limbus Corneae; Male; Middle Aged; Mycophenolic Acid; Prognosis; Prospective Studies; Stem Cell Transplantation; Stem Cells; Transplantation, Homologous | 2004 |
Efficacy of systemic cyclosporine A and amniotic membrane on rabbit conjunctival limbal allograft rejection.
Topics: Amnion; Animals; Combined Modality Therapy; Conjunctiva; Corneal Diseases; Cyclosporine; Disease Models, Animal; Epithelial Cells; Female; Graft Rejection; Graft Survival; Immunosuppressive Agents; Injections, Intramuscular; Rabbits; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous | 2005 |
Deep corneal neovascularization after implantation with intrastromal corneal ring segments.
Topics: Adult; Combined Modality Therapy; Corneal Diseases; Corneal Neovascularization; Corneal Stroma; Cyclosporine; Device Removal; Dilatation, Pathologic; Drug Therapy, Combination; Humans; Male; Prednisolone; Prostheses and Implants; Prosthesis Implantation | 2005 |
Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
Topics: Animals; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Candida albicans; Candidiasis; Corneal Diseases; Cyclosporine; Fluconazole; Immunosuppressive Agents; Keratitis; Mice; Mice, Inbred BALB C | 2006 |
Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Eye Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mitomycin | 2006 |
Clear graft survival and immune reactions following emergency keratoplasty.
Topics: Adult; Aged; Aged, 80 and over; Cornea; Corneal Diseases; Cryopreservation; Cyclosporine; Emergency Treatment; Graft Rejection; Graft Survival; Humans; Immune System; Immune Tolerance; Immunosuppressive Agents; Keratoplasty, Penetrating; Middle Aged; Mycophenolic Acid; Organ Culture Techniques; Organ Preservation; Prognosis; Retrospective Studies | 2007 |
Human allograft limbal transplantation for corneal surface reconstruction.
Topics: Adolescent; Adult; Aged; Burns, Chemical; Child; Child, Preschool; Cornea; Corneal Diseases; Corneal Injuries; Corneal Transplantation; Cyclosporine; Epithelium; Eye Burns; Female; Graft Rejection; Humans; Infant; Limbus Corneae; Male; Middle Aged; Stem Cell Transplantation; Transplantation, Homologous | 1994 |
Influence of topically applied cyclosporine A in olive oil on corneal epithelium permeability.
Topics: Administration, Topical; Adult; Cell Membrane Permeability; Cornea; Corneal Diseases; Cyclosporine; Emulsions; Female; Fluorescein; Fluoresceins; Fluorophotometry; Humans; Male; Olive Oil; Ophthalmic Solutions; Plant Oils; Pruritus | 1994 |
[Cyclosporin in ophthalmology].
Topics: Administration, Topical; Corneal Diseases; Corneal Transplantation; Cyclosporine; Humans; Kidney Tubules | 1993 |
Therapeutic use of topical cyclosporine.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Conjunctivitis, Allergic; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions; Prognosis; Recurrence; Risk Factors | 1993 |
Limbal transplantation.
Topics: Adolescent; Adult; Cell Transplantation; Corneal Diseases; Corneal Transplantation; Cyclosporine; Epithelium; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Limbus Corneae; Male; Middle Aged; Transplantation, Autologous; Transplantation, Homologous; Visual Acuity; Wound Healing | 1996 |
Cyclosporine A and the equine cornea.
Topics: Animals; Cornea; Corneal Diseases; Cyclosporine; Horse Diseases; Horses; Uveitis | 1995 |
Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders.
Topics: Adult; Aged; Aged, 80 and over; Cell Membrane Permeability; Cell Survival; Cell Transplantation; Cornea; Corneal Diseases; Cyclosporine; Dexamethasone; Epithelium; Female; Graft Rejection; Humans; Immunosuppressive Agents; Limbus Corneae; Male; Middle Aged; Organ Preservation; Tissue Donors; Transplantation, Homologous | 1995 |
Survival of rabbit limbal stem cell allografts after administration of cyclosporin A.
Topics: Animals; Aqueous Humor; Cell Transplantation; Corneal Diseases; Cyclosporine; Disease Models, Animal; Epithelial Cells; Follow-Up Studies; Graft Survival; Immunosuppressive Agents; Injections, Intramuscular; Limbus Corneae; Male; Ophthalmic Solutions; Rabbits; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 1999 |
Carcinoma of the corneoscleral limbus in a patient treated with cyclosporine after heart transplantation.
Topics: Carcinoma in Situ; Corneal Diseases; Cyclosporine; Eye Neoplasms; Heart Transplantation; Humans; Immunosuppressive Agents; Limbus Corneae; Male; Middle Aged | 1999 |
Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A.
Topics: Adolescent; Adult; Aged; Child; Corneal Diseases; Cyclosporine; Dermatitis, Atopic; Graft Survival; Humans; Immunosuppressive Agents; Keratitis; Keratoconus; Keratoplasty, Penetrating; Middle Aged; Postoperative Care; Prognosis; Retrospective Studies | 1999 |
[Amniotic membrane transplantation with or without limbal allografts in corneal surface reconstruction in limbal deficiency].
Topics: Amnion; Cell Transplantation; Contact Lenses; Corneal Diseases; Cyclosporine; Epithelium, Corneal; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Limbus Corneae; Postoperative Care; Prospective Studies; Time Factors | 2000 |
Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Cell Transplantation; Corneal Diseases; Cyclosporine; Epithelial Cells; Epithelium, Corneal; Female; Graft Rejection; Graft Survival; Humans; Keratoplasty, Penetrating; Limbus Corneae; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2002 |
Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Cornea; Corneal Diseases; Cyclosporine; Female; Humans; Male; Middle Aged; Scleritis | 1992 |
Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Infant; Keratoplasty, Penetrating; Male; Middle Aged; Premedication; Risk Factors; Tissue Donors | 1992 |